A second example is the TNFAIPI-POLDIP2 S-AS gene pair, whose co-regulated expression is associated with breast cancer phenotypes and patient survival, suggesting the therapeutic approach needs to take genes in this complex sense-antisense architecture into consideration (Grinchuk et al., 2010). This evidence concerns the gene POLDIP2 and breast carcinoma.